Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: A nationwide study

Blood

Volumn 118, Issue 15, 2011, Pages 4062-4069

  Nielsen, Sune F ^a,b   Bojesen, Stig E ^a,b   Birgens, Henrik S ^a,b   Nordestgaard, Børge G ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID CANCER;

EID: 80054121738     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-337170     Document Type: Article

References (37)

1. Bhatia S, Sather HN, Pabustan OB, et al. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood. 2002;99(12):4257-4264. (Pubitemid 34627190)
2. Chow EJ, Friedman DL, Stovall M, et al. Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatric Blood Cancer. 2009;53(3): 432-437.
3. Eguiguren JM, Ribeiro RC, Pui CH, et al. Secondary non-Hodgkin lymphoma after treatment for childhood cancer. Leukemia. 1991;5(10):908-911.
4. Gow KW, Lensing S, Hill DA, et al. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: an institutional experience and review of the literature. J Pediatr Surg. 2003;38(11):1574-1580. (Pubitemid 37413852)
5. Maule M, Scelo G, Pastore G, et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst. 2007;99(10):790-800. (Pubitemid 47073525)
6. Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008; 111(12):5515-5523.
7. Borgmann A, Zinn C, Hartmann R, et al. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer. 2008;44(2):257-268.
8. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic-bomb survivors. 3. Leukemia, lymphoma and multiple-myeloma, 1950- 1987. Radiat Res. 1994;137(2):S68-S97.
9. Kaatsch P, Reinisch I, Spix C, et al. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany. Cancer Causes Control. 2009;20(6): 965-980.
10. Philip A. Pizzo DGP. Principles and Practice of Pediatric Oncology. Philadelphia: PA: Lippincott Wiliams & Wilkins; 2010.
11. Souhami R. Oxford Textbook of Oncology. Oxford, United Kingdom: Oxford University Press; 2011.
12. Mitchell AE, Scarcella DL, Rigutto GL, et al. Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust. 2004; 180(2):59-62. (Pubitemid 38173137)
13. Ponisch W, Niederwieser D. Late effects after chemotherapy. Internist. 2006;47(3):266.
14. Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011;29(5): 532-543.
15. Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008;112(5):1646-1654.
16. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry: history, content, quality and use. Dan Med Bull. 1997;44(5):535- 539.
17. Storm HH. The Danish Cancer Registry, a selfreporting national cancer registration system with elements of active data collection. IARC Sci Publ. 1991;95:220-236.
18. Storm HH. Available data sources and linkage possibilities using cancer registry data in the evaluation of clinical cancer care. IARC Tech Publ. 2003;38:19-22.
19. Ahmad O, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age Standardization of Rates: A New WHO Standard. Geneva, Switzerland: World Health Organization; 2001.
20. Bhatia S, Meadows AT. Long-term follow-up of childhood cancer survivors: future directions for clinical care and research. Pediatr Blood Cancer. 2006;46(2):143-148. (Pubitemid 43076063)
21. Hawkins MM. Long-term survivors of childhood cancers: what knowledge have we gained? Nat Clin Pract Oncol. 2004;1(1):26-31. (Pubitemid 40812645)
22. Inskip PD. Thyroid cancer after radiotherapy for childhood cancer. Med Pediatr Oncol. 2001; 36(5):568-573. (Pubitemid 32336564)
23. Inskip PD. Second cancers following radiotherapy. In: Neugut AI, ed. Multiple Primary Cancers. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.
24. Pui CH. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med. 2003;349(13):1299.
25. Pui CH, Evans WE. Drug therapy: treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-178. (Pubitemid 43076714)
26. Nygaard R, Garwics S, Haldorsen T, et al. Second neoplasms in patients treated for childhood leukemia: a population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO). Acta Paediatr Scand. 1991;80(12):1220-1228.
27. Tucker MA, Jones PHM, Boice JD, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res. 1991;51(11): 2885-2888.
28. Hisada M, Biggar RJ, Greene MH, Fraument JF, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98(6):1979-1981.
29. Smith MT, Zhang LP. Biomarkers of leukemia risk: benzene as a model. Environ Health Perspect. 1998;106(suppl 4):937-946. (Pubitemid 28419776)
30. Greaves MF. Aetiology of acute leukaemia. Lancet. 1997;349(9048):344-349. (Pubitemid 27056837)
31. Yang CJ, Chen MY, Hsieh SM, et al. Non- Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan. J Microbiol Immunol Infect. 2010;43(4):278-284.
32. Navarro JT, Hernandez A, Rodriguez-Manzano J, et al. Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIVinfected patients. Med Clin. 2010;135(11):485- 490.
33. Newsom-Davis T, Ahamed E, Bower M. Immunotherapy for HIV-associated non-Hodgkin's lymphoma. Expert Opin Biol Ther. 2009;9(10):1313- 1324.
34. Illes A, Varoczy L, Papp G, et al. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy. Scand J Immunol. 2009;69(5):387-400.
35. Bluhm EC, Ronckers C, Hayashi RJ, et al. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2008;111(8):4014-4021.
36. Garwicz S, Anderson H, Olsen JH, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based casecontrol study in the 5 Nordic countries. Int J Cancer. 2000;88(4):672-678.
37. Tsimberidou AM, Keating MJ. Richter syndrome. Cancer. 2005;103(2):216-228.